PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $223,000 | -60.7% | 4,185 | -57.0% | 0.00% | -75.0% |
| Q2 2022 | $567,000 | -38.3% | 9,722 | -19.2% | 0.00% | -33.3% |
| Q1 2022 | $919,000 | +500.7% | 12,035 | +374.6% | 0.01% | +500.0% |
| Q4 2021 | $153,000 | +12.5% | 2,536 | +4.1% | 0.00% | 0.0% |
| Q3 2021 | $136,000 | -28.4% | 2,437 | -22.0% | 0.00% | -50.0% |
| Q2 2021 | $190,000 | -65.8% | 3,124 | -60.6% | 0.00% | -66.7% |
| Q1 2021 | $555,000 | +115.1% | 7,925 | +84.1% | 0.01% | +100.0% |
| Q4 2020 | $258,000 | +9.3% | 4,305 | +9.3% | 0.00% | -25.0% |
| Q3 2020 | $236,000 | +26.9% | 3,938 | +12.3% | 0.00% | +33.3% |
| Q2 2020 | $186,000 | +102.2% | 3,507 | +22.6% | 0.00% | +50.0% |
| Q1 2020 | $92,000 | – | 2,860 | +18966.7% | 0.00% | – |
| Q1 2018 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |